SCHEMBL27416713

SCHEMBL27416713

CC(C)c1nc(C(=O)NC(C)(C)C)ccc1C#N

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 6/20 0.40
▸ ALDH1A1 P00352 2/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ TP53 P04637 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ SCN9A Q15858 1/20 0.36
▸ LRRK2 Q5S007 1/20 0.35
▸ PRKAB2 O43741 1/20 0.35
▸ PRKAG1 P54619 1/20 0.35
▸ PRKAA2 P54646 1/20 0.35
▸ PRKAA1 Q13131 1/20 0.35
▸ PRKAG3 Q9UGI9 1/20 0.35
▸ PRKAG2 Q9UGJ0 1/20 0.35
▸ PRKAB1 Q9Y478 1/20 0.35
▸ ANO1 Q5XXA6 1/20 0.35
▸ CTSB P07858 1/20 0.34
▸ AR P10275 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27416076 0.81 CNR2 (0.41) CNR2ALDH1A1KDM4ENPC1TP53
SCHEMBL12857451 0.80 XDH (0.45) KDM4EL3MBTL1
SCHEMBL27416080 0.78 MAPK8 (0.42) CNR2ALDH1A1KDM4ENPC1TP53
SCHEMBL25676424 0.70 CBLB (0.41) CNR2ALDH1A1PRKAB2PRKAG1PRKAA2
SCHEMBL18157899 0.69 POLB (0.50) CNR2ALDH1A1KDM4ENPC1RAB9A
SCHEMBL22099890 0.69 EGLN1 (0.47) ANO1
SCHEMBL20122613 0.68 PRKAB2 (0.39) CNR2ALDH1A1KDM4EPRKAB2PRKAG1
SCHEMBL25694574 0.68 HTT (0.34) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL12141866 0.68 HRH4 (0.41) ALDH1A1KDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL26772954 0.67 NPC1 (0.48) CNR2ALDH1A1NPC1TP53RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240207425-A1 AURISTATIN LINKER-PAYLOADS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF MERCK SHARP & DOHME LLC (US) 2024-06-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240207425-A1 AURISTATIN LINKER-PAYLOADS, PHARMACEUTICAL COMPOSITIONS, AND USES THEREOF AURKA, AURKC, AURKB CNR2 3127/4885ALDH1A1 990/4885KDM4E 1176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback